148 related articles for article (PubMed ID: 17007443)
1. Cyclooxygenase-2 (cox-2) expression and angiogenesis in intracranial ependymomas.
Onguru O; Kurt B; Gunhan O; Soylemezoglu F
Clin Neuropathol; 2006; 25(5):216-20. PubMed ID: 17007443
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma.
Onguru O; Gamsizkan M; Ulutin C; Gunhan O
Neuropathology; 2008 Feb; 28(1):29-34. PubMed ID: 18181832
[TBL] [Abstract][Full Text] [Related]
3. Tumor vessel biology in pediatric intracranial ependymoma.
Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
[TBL] [Abstract][Full Text] [Related]
4. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
5. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
6. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD
Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclooxygenase-2 in childhood ependymomas: role of COX-2 inhibitor in growth and multi-drug resistance in vitro.
Kim SK; Lim SY; Wang KC; Kim YY; Chi JG; Choi YL; Shin HJ; Cho BK
Oncol Rep; 2004 Aug; 12(2):403-9. PubMed ID: 15254709
[TBL] [Abstract][Full Text] [Related]
8. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Millanta F; Citi S; Della Santa D; Porciani M; Poli A
Breast Cancer Res Treat; 2006 Jul; 98(1):115-20. PubMed ID: 16538539
[TBL] [Abstract][Full Text] [Related]
9. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA
Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis.
Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH; Chai CY
APMIS; 2009 Mar; 117(3):176-84. PubMed ID: 19245590
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth.
Lee JS; Choi YD; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Kim HS; Min KW
Gynecol Oncol; 2004 Dec; 95(3):523-9. PubMed ID: 15581957
[TBL] [Abstract][Full Text] [Related]
12. Correlation of p53 and KI-67 expression with grade and subtype of ependymoma.
Manasa LP; Uppin MS; Sundaram C
Indian J Pathol Microbiol; 2012; 55(3):308-13. PubMed ID: 23032822
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions.
Horn LC; Hentschel B; Meinel A; Alexander H; Leo C
Ann Diagn Pathol; 2009 Dec; 13(6):373-7. PubMed ID: 19917472
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of cell cycle/apoptosis regulators and epidermal growth factor receptor in pediatric intracranial ependymomas.
Alexiou GA; Stefanaki K; Moschovi M; Patereli A; Prodromou N; Karentzou O
J Child Neurol; 2011 Feb; 26(2):195-8. PubMed ID: 20713981
[TBL] [Abstract][Full Text] [Related]
15. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression in human pituitary tumors.
Vidal S; Kovacs K; Bell D; Horvath E; Scheithauer BW; Lloyd RV
Cancer; 2003 Jun; 97(11):2814-21. PubMed ID: 12767095
[TBL] [Abstract][Full Text] [Related]
17. COX-2 expression does not correlate with microvessel density in breast cancer.
Thorat MA; Mehrotra S; Morimiya A; Badve S
Pathobiology; 2009; 76(1):39-44. PubMed ID: 19188749
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of angiogenesis in rectal carcinoid tumors.
Onogawa S; Tanaka S; Oka S; Morihara M; Kitadai Y; Sumii M; Yoshihara M; Shimamoto F; Haruma K; Chayama K
Oncol Rep; 2002; 9(3):489-94. PubMed ID: 11956615
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclo-oxygenase-2 in ependymal tumors.
Roma AA; Prayson RA
Neuropathology; 2006 Oct; 26(5):422-8. PubMed ID: 17080719
[TBL] [Abstract][Full Text] [Related]
20. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance.
Shibata M; Kodani I; Osaki M; Araki K; Adachi H; Ryoke K; Ito H
Oral Oncol; 2005 Mar; 41(3):304-12. PubMed ID: 15743693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
